Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Change in Inventory (2016 - 2025)

Avanos Medical's Change in Inventory history spans 11 years, with the latest figure at -$44.9 million for Q4 2024.

  • For Q4 2024, Change in Inventory fell 297.35% year-over-year to -$44.9 million; the TTM value through Dec 2024 reached -$39.0 million, down 729.79%, while the annual FY2025 figure was -$200000.0, 99.49% up from the prior year.
  • Change in Inventory for Q4 2024 was -$44.9 million at Avanos Medical, down from -$1.9 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $20.6 million in Q2 2020 and bottomed at -$44.9 million in Q4 2024.
  • The 5-year median for Change in Inventory is $1.1 million (2021), against an average of -$455000.0.
  • The largest annual shift saw Change in Inventory tumbled 1836.36% in 2020 before it surged 2077.78% in 2022.
  • A 5-year view of Change in Inventory shows it stood at -$19.1 million in 2020, then skyrocketed by 69.63% to -$5.8 million in 2021, then rose by 15.52% to -$4.9 million in 2022, then crashed by 130.61% to -$11.3 million in 2023, then tumbled by 297.35% to -$44.9 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Change in Inventory are -$44.9 million (Q4 2024), -$1.9 million (Q3 2024), and $3.1 million (Q2 2024).